Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

406 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1.
Vlassara H, Cai W, Goodman S, Pyzik R, Yong A, Chen X, Zhu L, Neade T, Beeri M, Silverman JM, Ferrucci L, Tansman L, Striker GE, Uribarri J. Vlassara H, et al. Among authors: yong a. J Clin Endocrinol Metab. 2009 Nov;94(11):4483-91. doi: 10.1210/jc.2009-0089. Epub 2009 Oct 9. J Clin Endocrinol Metab. 2009. PMID: 19820033 Free PMC article.
Change in subjective well-being and the associated costs of a woman-targeted presbyopia correction programme among older craftswomen in Zanzibar: a cost-outcome and scenario analysis.
Chan VF, Othman OJ, Yong AC, Graham C, Price-Sanchez C, Pillai BS, Holland E, McConnell E, Jones J, Farmer A, Martins MF, Shah K, Mulewa D, Graham R, Mashayo E, Omar F. Chan VF, et al. Among authors: yong ac. Br J Ophthalmol. 2025 Jan 29:bjo-2024-325887. doi: 10.1136/bjo-2024-325887. Online ahead of print. Br J Ophthalmol. 2025. PMID: 39880670 Free article.
Microwave-Energy-Based Device for the Treatment of Cellulite and Localized Adiposity: Recommendations of the "Onda Coolwaves" International Advisory Board.
Hoffmann K, Zappia E, Bonan P, Coli F, Bennardo L, Clementoni MT, Pedrelli V, Piccolo D, Poleva I, Salsi B, Cuciti C, Tarico MS, Incandela C, Nunziata CA, D'Andrea F, Perosino E, Carpagnano S, Abramo P, Yong AA, Paschoal RS, Romero MDV, Rosas AIR, Galimberti DR, Matekovits A, Kjeldsen SH, Jensen T, Mezzana P, Msallam H, Ribero S, Nisticò SP. Hoffmann K, et al. Among authors: yong aa. Bioengineering (Basel). 2024 Dec 9;11(12):1249. doi: 10.3390/bioengineering11121249. Bioengineering (Basel). 2024. PMID: 39768067 Free PMC article. Review.
The Evolution of Treatment-Free Remission.
Hughes TP, Yong AS, Ross DM. Hughes TP, et al. Among authors: yong as. Blood. 2025 Jan 6:blood.2024026310. doi: 10.1182/blood.2024026310. Online ahead of print. Blood. 2025. PMID: 39761414
CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting.
Lim K, Kan WL, Nair PC, Kutyna M, Lopez AF, Hercus T, Ross DM, Lane S, Fong CY, Brown A, Yong A, Yeung D, Hughes T, Hiwase D, Thomas D. Lim K, et al. Among authors: yong a. PLoS One. 2024 Sep 19;19(9):e0310641. doi: 10.1371/journal.pone.0310641. eCollection 2024. PLoS One. 2024. PMID: 39298477 Free PMC article. Clinical Trial.
406 results